BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 32376308)

  • 1. Lymphopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A systemic review and meta-analysis.
    Zhao Q; Meng M; Kumar R; Wu Y; Huang J; Deng Y; Weng Z; Yang L
    Int J Infect Dis; 2020 Jul; 96():131-135. PubMed ID: 32376308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphopenia and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Among Hospitalized Obstetric Patients.
    Duffy CR; Hart JM; Modest AM; Hacker MR; Golen T; Li Y; Zera C; Shainker SA; Mehrotra P; Zash R; Wylie BJ
    Obstet Gynecol; 2020 Aug; 136(2):229-231. PubMed ID: 32433451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphopenia and neutrophilia at admission predicts severity and mortality in patients with COVID-19: a meta-analysis.
    Henry B; Cheruiyot I; Vikse J; Mutua V; Kipkorir V; Benoit J; Plebani M; Bragazzi N; Lippi G
    Acta Biomed; 2020 Sep; 91(3):e2020008. PubMed ID: 32921706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors of severe cases with COVID-19: a meta-analysis.
    Ou M; Zhu J; Ji P; Li H; Zhong Z; Li B; Pang J; Zhang J; Zheng X
    Epidemiol Infect; 2020 Aug; 148():e175. PubMed ID: 32782035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective CD8 cell reduction by SARS-CoV-2 is associated with a worse prognosis and systemic inflammation in COVID-19 patients.
    Urra JM; Cabrera CM; Porras L; Ródenas I
    Clin Immunol; 2020 Aug; 217():108486. PubMed ID: 32479985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe COVID-19 is associated with deep and sustained multifaceted cellular immunosuppression.
    Jeannet R; Daix T; Formento R; Feuillard J; François B
    Intensive Care Med; 2020 Sep; 46(9):1769-1771. PubMed ID: 32514592
    [No Abstract]   [Full Text] [Related]  

  • 7. COVID-19 pneumonia in a multiple sclerosis patient with severe lymphopenia due to recent cladribine treatment.
    Dersch R; Wehrum T; Fähndrich S; Engelhardt M; Rauer S; Berger B
    Mult Scler; 2020 Sep; 26(10):1264-1266. PubMed ID: 32762488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis.
    Lippi G; Plebani M; Henry BM
    Clin Chim Acta; 2020 Jul; 506():145-148. PubMed ID: 32178975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Case of COVID-19 and
    Menon AA; Berg DD; Brea EJ; Deutsch AJ; Kidia KK; Thurber EG; Polsky SB; Yeh T; Duskin JA; Holliday AM; Gay EB; Fredenburgh LE
    Am J Respir Crit Care Med; 2020 Jul; 202(1):136-138. PubMed ID: 32412848
    [No Abstract]   [Full Text] [Related]  

  • 10. Relative lymphocytosis in COVID-19 - a ray of hope.
    Ish P; Malhotra N; Agrawal S; Gupta N
    Adv Respir Med; 2020; 88(3):287-288. PubMed ID: 32706115
    [No Abstract]   [Full Text] [Related]  

  • 11. Laboratory Tests and Outcome for Patients with Coronavirus Disease 2019: A Systematic Review and Meta-Analysis.
    Alnor A; Sandberg MB; Gils C; Vinholt PJ
    J Appl Lab Med; 2020 Sep; 5(5):1038-1049. PubMed ID: 32573713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association Between ABO Blood Group System and COVID-19 Susceptibility in Wuhan.
    Fan Q; Zhang W; Li B; Li DJ; Zhang J; Zhao F
    Front Cell Infect Microbiol; 2020; 10():404. PubMed ID: 32793517
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical Characteristics and Risk Factors of Acute Respiratory Distress Syndrome (ARDS) in COVID-19 Patients in Beijing, China: A Retrospective Study.
    Wang A; Gao G; Wang S; Chen M; Qian F; Tang W; Xu Y; Song R; Zhuang L; Ma X; Zhao T; Guo X; Li W; Wang X; Li B; Hu C; Chen Z; Zhang F
    Med Sci Monit; 2020 Sep; 26():e925974. PubMed ID: 32973126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics and co-infections of 354 hospitalized patients with COVID-19 in Wuhan, China: a retrospective cohort study.
    Lv Z; Cheng S; Le J; Huang J; Feng L; Zhang B; Li Y
    Microbes Infect; 2020; 22(4-5):195-199. PubMed ID: 32425649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostaglandin D
    Gupta A; Chander Chiang K
    Med Hypotheses; 2020 Oct; 143():110122. PubMed ID: 32759007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Severe Acute Respiratory Syndrome Coronavirus 2 Infection on Pregnant Women and Their Infants.
    Yang H; Hu B; Zhan S; Yang LY; Xiong G
    Arch Pathol Lab Med; 2020 Oct; 144(10):1217-1222. PubMed ID: 32422078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors and laboratory test results associated with severe illness and mortality in COVID-19 patients: A systematic review.
    Setiati S; Harimurti K; Safitri ED; Ranakusuma RW; Saldi SRF; Azwar MK; Marsigit J; Pitoyo Y; Widyaningsih W
    Acta Med Indones; 2020 Jul; 52(3):227-245. PubMed ID: 33020334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dyslipidemia is associated with severe coronavirus disease 2019 (COVID-19) infection.
    Hariyanto TI; Kurniawan A
    Diabetes Metab Syndr; 2020; 14(5):1463-1465. PubMed ID: 32771919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical course and its correlated immune status in COVID-19 pneumonia.
    He R; Lu Z; Zhang L; Fan T; Xiong R; Shen X; Feng H; Meng H; Lin W; Jiang W; Geng Q
    J Clin Virol; 2020 Jun; 127():104361. PubMed ID: 32344320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous thrombocytopenia after SARS-CoV-2 nucleic acid negative in a non-severe COVID-19 patient for several months.
    Wu X; Luo D; Liu Y; Zeng Y; Gong Y
    BMC Infect Dis; 2020 Oct; 20(1):774. PubMed ID: 33076856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.